drugset / Trial / NCT06907316

Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis

NCT06907316

RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates the efficacy (non-inferiority) and safety of a new antibiotic treatment (cefixime), which has been previously used for single dose therapy of gonorrhoea in many years , in the treatment of early syphilis. Participants will be randomized to one of two study arms and will receive either expirimental regimen (cefixime) or the current standard antibiotic regimen (benzathine penicillin G). New treatment alternatives for syphilis could ensure that people are appropriately treated during periods or in settings of benzathine penicillin G stock out, penicillin allergy, or other intolerance to penicillin injection. This study may also identify an oral regimen for settings in which injections are not feasible.

Timeline

Start
2021-07-13
Primary completion
2024-08-01
Completion
2024-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzathine Penicillin G Unknown 2.4 iu Intramuscular
Subject Cefixime Other / unclassified 400 mg Oral

Indications